References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
Gonorrhoea is the second most commonly diagnosed bacterial STI in the UK, and rates have been rising over recent years. It disproportionately affects men who have sex with men (MSM), young adults and urban populations. Antibiotic resistance is a growing concern, making accurate diagnosis and proper treatment more important than ever.
Order a discreet home STI test
UK Trends
| Fact | Detail |
|---|---|
| Trend | Rising diagnoses over recent years |
| Most affected group | MSM, young adults 15-24 |
| Geographic pattern | Higher rates in London and major cities |
| Resistance | Growing concern; ceftriaxone remains effective |
Why Rates Are Rising
- Better testing detecting more cases
- Reduced condom use in some populations
- Larger sexual networks
- More testing at throat and rectal sites
Who Is Most Affected
- Men who have sex with men
- Young adults aged 15-24
- Black African and Caribbean communities
- Urban populations
Prevention
- Condoms
- Regular testing (every 3 months for higher-risk MSM)
- Partner notification and treatment
- Possible partial protection from meningitis B vaccine
Read more: What is gonorrhoea? | Gonorrhoea treatment | UK STI rates
Frequently Asked Questions
Is gonorrhoea still curable?
Yes — current antibiotics remain effective.
How is it tested?
Urine or swab NAAT, including throat and rectal.
Should I test if I have no symptoms?
Yes — many cases are silent.
Related reading
- Multi-Site STI Testing: Genital, Rectal and Throat
- What Is Gonococcal Arthritis?
- What Is Super Gonorrhoea?
- Why Is Gonorrhoea Called 'The Clap'?
- Blood Test for Syphilis, Hepatitis B and Hepatitis C
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
